Abstract:hope to use this technology for studying complex behaviors in NHPs in order to dissect functional neural circuits and to develop clinically relevant stimulation-based approaches to treating human neurological diseases [2]. However there are several challenges that remain for conducting long-term optogenetic experiments in these animals. One of the challenges is delivering a large volume of virus into a specific region of the cortex. Conventional injection techniques use multiple small injections and rely on diffusion of the viral vector from the injection site, typically over a range of 1-3 mm. Due to the large size of cortical regions in these animals, this approach is time consuming and delivers highly variable density of viral vector over the region. Therefore, we see a need for a technique to deliver these viruses more efficiently and more evenly across the target tissue. In addition with conventional techniques, one cannot precisely localize the injection site within the tissue to monitor the spread of virus during infusion. We have addressed these issues using a Convection Enhanced Delivery (CED) technique that has been developed for other gene-therapy methods [3]. In this technique relatively large volumes are injected with sufficient pressure to drive bulk fluid flow (convection), and hence achieve a wider and more even distribution of the vector. In addition, we have performed these injections in the MRI scanner in order to obtain real-time visualization of the site of injection and the spread of viral vector. We have used a reflux-resistant cannula [3] to infuse an AAV9-CamKIIa-ChR2-EYFP viral vector into the primary somatosensory cortex of a rhesus macaque monkey. The cannula was inserted 2 mm below the surface of the brain. To monitor the infusion via real-time MR images, the viral vector was co-infused with a gadolinium MR contrast agent (See Figure 1). The initial infusion rate started with 1 uL/min and was increased to 5 uL/min by 1 uL/min steps as the spread of the virus was monitored in the cortical region. The virus was infused at two sites and 47 uL was injected through each site (Figure 1b and 1c). After eight weeks recovery, and under pentobarbital anesthesia, surface illumination and imaging was used to confirm the presence of the EYFP fluorescent reporter [4]. Later histological analysis, using immunostaining against the reporter, was performed. We observed widespread and dense ChR2 expression in areas 1, 2, 3a and 3b of cortex. The highest expression was observed in areas 1 and 3b, which were closer to the site of injection. This technique enables us to obtain expression across larger areas of cortex in a shorter period of time with minimal damage compared to the current techniques [4] and can be an optimal approach for optogenetics viral delivery in NHPs.

Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brains.

Transgenic Rhesus Monkeys Produced by Gene Transfer into Early-Cleavage–stage Embryos Using a Simian Immunodeficiency Virus-Based Vector

Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System

A mosaic adeno-associated virus vector as a versatile tool that exhibits high levels of transgene expression and neuron specificity in primate brain

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system

A novel technique for infusion of optogenetics viral vectors in non-human primates ( NHPs ) cortex using MR-guided convection enhanced delivery ( CED )

Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations

Liver-directed gene transfer in non-human primates

High-Level Transgene Expression in Nonhuman Primate Liver with Novel Adeno-Associated Virus Serotypes Containing Self-Complementary Genomes

Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells.

Different Serotypes of Adeno-Associated Virus Vector- and Lentivirus-Mediated Tropism in Choroid Plexus by Intracerebroventricular Delivery.

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain

Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development

Gene-transfer and Expression Efficiencies of Recombinant Lentivirus in Different Mammalian Cell Lines

Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice

Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans

Gene Transfer into the Nervous System using Recombinant Herpes Virus Vectors

Biological Differences in Raav Transduction of Airway Epithelia in Humans and in Old World Non-Human Primates

Targeted Transgene Expression in Cholinergic Interneurons in the Monkey Striatum Using Canine Adenovirus Serotype 2 Vectors